Amgen (NASDAQ:AMGN) reported quarterly earnings results on February 03, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $5.29,…
Amgen (NASDAQ:AMGN) reported quarterly earnings results on February 03, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $5.29, beating the consensus estimate of $4.75 by $0.54 per share. Revenue came in at $9.9B, beating the estimate of $9.5B.
Amgen's stock moved following the earnings release. The stock currently trades at $352.09 with a market capitalization of $170.9B.
Current market data
NASDAQ · AMGN
$406.04
Up: +$3.21 · +0.79%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
